All Nippon Airways transport COVID-19 Vaccine through COVAX Facility

All Nippon Airways transport COVID-19 Vaccine through COVAX Facility 

All Nippon Airways (ANA) has partnered with the global transport and logistics provider Scan Global Logistics for the international transportation of COVID-19 vaccines manufactured in Japan to Cambodia, Bangladesh, Sri Lanka, Laos, East Timor, Fiji, and Maldives through the Japanese government's cooperation with the COVAX facility.

The COVAX Facility is a logistical hub designed to maximize resource mobilization and supply coordination led by Gavi, the global vaccine alliance leading COVAX efforts. The initiative aims to secure equitable access to vaccines worldwide regardless of income levels and increasing availability in developing nations throughout Southeast Asia is key to this strategy. 

The transportation of vaccines present a number of logistical hurdles, requiring ANA to leverage its full range of expertise and experience gained at the forefront of cargo transportation. 

As part of its efforts to make flying safer, ANA has instituted the ANA Care Promise, a comprehensive series of protocols designed to prevent the spread of COVID-19. As the COVID-19 pandemic continues to affect nearly every aspect of life, ANA remains committed to doing all it can to empower healthcare workers and public health professionals worldwide.